Chyle fistula. Medical management with octreotide;Fístula del conducto torácico. Tratamiento médico con octreótida

Cirugia Espanola

Volumn 79, Issue 4, 2006, Pages 250-251

  Bejarano Glez Serna, Daniel ^a   Utrera Glez, Antonio ^a   Cordoncillo Prieto, José María ^a   De Juan, Fernando De La Portilla ^a   Rada Morgades, Ricardo ^a   Carranza Albarran, Gonzalo ^a  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

Author keywords

Chyle fistula; Octreotide

Indexed keywords

GASTROINTESTINAL AGENT; OCTREOTIDE;

AGED; ARTICLE; CASE REPORT; CHYLE; FEMALE; FISTULA; HUMAN; INJURY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; THORACIC DUCT;

AGED; CHYLE; FEMALE; FISTULA; GASTROINTESTINAL AGENTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; OCTREOTIDE; POSTOPERATIVE COMPLICATIONS; THORACIC DUCT;

EID: 33745888413     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(06)70862-4     Document Type: Article

References (8)

1. Markham KM, Glover JL, Welsh RJ, Lucas RJ, Benndick PJ. Octeótride in the treatment of thoracic duct injuries. American Súrg. 2000;66:12.
2. Kelly RF, Shumway SJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thrac Surg. 2000;69:1944-5.
3. Ulibarri JI, Sanz Y, Fuentes C, et al. Reduction of lymphorragia from ruptured thoracic duct by somatostatin. Lancet. 1990;336:258.
4. Giordano M, Cirillo D, Baron I. Treatment of postraumatic chyluria with subcutaneous Octeótride administration. Nephrol Dial Trasplant. 1996;11:365-7.
5. Nyquist GG, Hagr A, Sobol SE, Hier MP, Black MJ. Octeótride in the medical management of chyle fistula. Otolaryngol Head Neck Surg. 2003;128:910-1.
6. Bolger C, Walsh T, Hennessy T. Chylothorax after esphagectomy. Br J Surg. 1991;78:587-8.
7. Crumley RL, Smith JD. Postoperative chylous fistula prevention and management. Laryngoscope. 1976;86:804-13.
8. Nussenbaum B, Liu JH, Sinard RJ. Systematic management of chyle fistula: the Southwetern experience and review of the literature. Otolaryngol Head Neck Surg. 2000;122:31-8.